Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

Meina Tao Tang - Principal Scientist, Clinical Pharmacology

Meina Tao Tang

Principal Scientist, Clinical Pharmacology

"Genentech is well known for its scientific rigor and commitment in “medical innovations for all”. I am very proud to be a scientist at Genentech and appreciate the opportunities to contribute to multiple development programs that have the potential to improve patient’s lives. It is truly amazing what we learn and discover by “following the science” in our daily work. Translating scientific principles into life-changing medications is my motivation coming to work every day."
Years at Genentech
Awards & Honors

Dr. Tang is a principal scientist and therapeutic area lead for autoimmune/inflammation diseases in the department of clinical pharmacology within the development science organization. Soon after joining Genentech in 2009, Dr. Tang was appointed as the pharmacology sub-team leader for two biologic programs and was the clinical pharmacology functional lead managing 8 development programs within inflammation and autoimmune disease areas.

Prior to joining Genentech, Dr. Tang was a Director of PK/PD at PDL Biopharma (previously named as “Protein Design Labs”). Overall, Dr. Tang has near 20 years of Biopharma/Biotech industry experience and was involved in the clinical development of 18 molecules, including monoclonal antibodies, F’ab fragment, Fusion protein and small molecule drugs, primarily in autoimmune or inflammatory disease areas including Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis, Lupus, Psoriasis and Asthma.

Featured Publication

Assessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative Colitis.

J Clin Pharmacol. 2016 Jun;56(6):693-704.

X Wei, J Kenny, L Dickmann, R Maciuca, C Looney, and M.T. Tang.

Short-Term Efficacy Reliably Predicts Long-Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model-Based Meta-Analysis.

J Clin Pharmacol. 2016 Jul;56(7):835-44.

Y Wang, R Zhu, JC Davis, JW Madnema, JY Jin, MT Tang